Biotricity is trading at $0.06 (-19.89%), with no clear company-specific catalyst identified. - The decline occurred on October 1, 2026; Biotricity’s news-release archive shows no announcement dated October 1. - Major indexes were near flat in a mixed broad market, which does not clearly explain the decline. Healthcare was also lower, but that sector context does not establish the cause.